Intuitive Surgical, Inc.

As of June 30, 2026, Intuitive Surgical, Inc. Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh carries a market capitalization of 778.95B, placing it among publicly traded companies globally. Its enterprise value stands at 752.65B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Intuitive Surgical, Inc. Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh's next confirmed earnings release is scheduled for January 26, 2027.

As of June 30, 2026, Intuitive Surgical, Inc. Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh has 7.05B shares outstanding.

As of June 30, 2026, Intuitive Surgical, Inc. Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh trades at a trailing price-to-earnings ratio of 48.18. The price-to-sales ratio is 13.70, and the price-to-book ratio stands at 8.29.

As of June 30, 2026, Intuitive Surgical, Inc. Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh trades at an EV/EBITDA multiple of 34.30 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 13.20 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 42.19 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. Intuitive Surgical, Inc. Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh trades at an EV/FCF ratio of 45.18, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 752.65B versus a market cap of 778.95B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Intuitive Surgical, Inc. Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh maintains a current ratio of 4.96, meaning it holds 5.0x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended June 30, 2026, Intuitive Surgical, Inc. Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh posted a return on equity (ROE) of 17.43, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 15.69 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 15.30, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 17.21, useful for judging operating efficiency across full business cycles. The company generates approximately 3.42M in revenue per employee across its workforce of 16,675.25, a quick read on workforce productivity versus industry peers. Inventory turnover of 1.99 indicates how many times Intuitive Surgical, Inc. Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Intuitive Surgical, Inc. Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh recorded 3.35B in income tax expense. That works out to an effective tax rate of 17.02, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 19.67B, leaving 16.22B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Intuitive Surgical, Inc. Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh's stock has declined approximately 22.24% over the past 52 weeks. The 50-day moving average sits at 101.33, while the 200-day moving average is 114.92.

Over the twelve months ended June 30, 2026, Intuitive Surgical, Inc. Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh generated 57.04B in revenue and converted that into 16.22B in net income, yielding earnings per share of 2.28. EBITDA reached 21.94B, while operating income came in at 17.84B.

These figures are as of June 30, 2026. Total book value stands at 93.91B, with working capital of 39.39B providing operational flexibility.

Intuitive Surgical, Inc. Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh produced 19.16B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -2.50B in capital expenditures, free cash flow totaled 16.66B - equivalent to 2.36 per share.

Over the twelve months ended June 30, 2026, Intuitive Surgical, Inc. Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh posted a gross margin of 66.68, reflecting its pricing power and cost economics. The operating margin of 31.28 and net profit margin of 28.45 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield stands at 2.10, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 2.40, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Intuitive Surgical, Inc. Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh shareholders.

Intuitive Surgical, Inc. Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh's most recent stock split took place on November 21, 2022 with a 1:2 split ratio.

As of June 30, 2026, Intuitive Surgical, Inc. Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh has an Altman Z-Score of 37.11, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.